readthroughSign in
CompanyALNYNasdaqCambridge, MA

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals develops RNAi therapeutics using siRNA to silence disease-causing mRNAs.

SCHEDULE 13GNov 16Latest SEC filing
Nov 13Latest story